Compelo Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More
Close
Dismiss

Osteotech Receives Approval For Plexur M Innovative Grafting

For orthopedic trauma, joint replacements, and oncology-related surgical procedures

Osteotech has reported that Plexur M (moldable) has been approved for use by 50 US hospitals to date. The company expects to receive additional approvals as Plexur M continues to gain mindshare among surgeons.

Plexur M is a bone-polymer composite of bioresorbable polymer and cortical bone fibers used in a variety of orthopedic procedures. Plexur M is highly differentiated from competing products by being the only radiopaque, moldable, settable and machinable bone graft implant that completely remodels into new bone.

Plexur M is a bone-polymer biocomposite of bioresorbable polymer and cortical bone fibers, built upon the company’s proprietary Plexur technology platform, may be used in a variety of orthopedic procedures.

Plexur M is moldable, settable, machinable and radiopaque and fully remodels into new host bone. Plexur M provides exceptional handling characteristics.

Sam Owusu-Akyaw, president and chief executive officer of Osteotech, said: “Since the advent of the controlled release in the US Plexur M has been used in a range of surgical procedures and is building a reputation as a go-to biologic for orthopedic surgeries requiring tailored solutions.

“As we have continued to communicate the differentiating advantages that Plexur M offers, we have gained mindshare among orthopedic surgeons focused on orthopedic trauma, joint replacements, and oncology-related procedures.”

David Lewallen, chair of orthopedic surgery at the Mayo Clinic in Rochester, Minnesota, said: “Plexur M has been very helpful in procedures involving uncontained defects where restoration of bone and avoidance of soft tissue impingement against the underlying implant is wanted. Short-term radiographic appearance is gratifying and long-term follow-up is ongoing.”